CAR-T Mesothelin (Yake Biotech)

N/A

Report date: 2022/03/03 10:05:47

Base Information

Drug NameCAR-T Mesothelin (Yake Biotech)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsAnti-Mesothelin

TargetsMesothelin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShanghai YaKe Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai YaKe Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A